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Abstract. Pentamidine is known to cause severe 
dysglycaemia by damaging ß-cell function of the 
pancreas. The exact mechanism still remains un-
clear. We report the case of a 53-year-old man in -
fected wi th the human immunodeficiency virus 
who developed insulin-dependent permanent dia-
betes mellitus 3 days after starting intravenous 
treatment with pentamidine for Pneumocystis 
carinii pneumonia. Discharged from hospital the 
daily need of insulin increased continuously over 
one year now requiring an average dose of 80 units 
per day. So far, a number of cases of insulin-depen-
dent diabetes mellitus following pentamidine thera-
py has been reported, but long-term observations 
are rare. 
Key words: Pentamidine - Diabetes mellitus - H u -
man immunodeficiency virus 
Insulin-dependent diabetes mellitus ( I D D M ) fol-
lowing parenteral pentamidine therapy in patients 
wi th the acquired immune-deficient syndrome 
(AIDS) has been described as a rare adverse event 
of the drug in a number of cases. Lit t le is known 
about the exact mechanism of action, and there are 
no reports of long-term follow-up except one case 
with a follow-up of 8 months after the onset of 
diabetes mellitus. We report the case of a patient 
wi th A I D S developing I D D M after pentamidine 
treatment. His need of insulin increased continu-
ously over 1 year. 
Case report 
A 53-year-old white man wi th known human i m -
munodeficiency virus (HIV) infection since 1985 
Abbreviations: A I D S = acquired immune-deficiency syndrome; 
H I V = human immunodeficiency virus; I D D M = insulin-de-
pendent diabetes mellitus 
Correspondence to: U . Liegl 
(current CD4 cell count 40/mm 3 ) presented wi th 
fever, dyspnea, and cough requiring hospital ad-
mission. Physical examination revealed a patient in 
reduced general health wi th a respiration rate of 
42/min and a heart rate of 104/min. Blood gas anal-
ysis showed severe hypoxemia ( p 0 2 49.4 mmHg). 
Life-threatening Pneumocystitis pneumonia was 
suspected although the patient had used pen-
tamidine inhalations for P. carinii prophylaxis dur-
ing the past 6 months wi th very good compliance. 
After demonstration of P. carinii in the bron-
chioalveolar lavage fluid high-dose intravenous 
cotrimoxazole therapy was started. The patient de-
veloped severe skin rash after 1 day, and cotrimox-
azole was therefore replaced by intravenous pen-
tamidine (4mg/kg). Methylprednisolone (100 mg/ 
day) was added for 2 days to improve hypoxia. 
Wi th in 2 weeks the pneumonia resolved; pen-
tamidine was given for a total of 15 days. 
After 3 days of pentamidine therapy asymp-
tomatic hyperglycemia occurred, wi th serum glu-
cose levels ranging up to 520 mg/dl requiring in-
sulin therapy. Before pentamidine administration 
routine blood glucose tests had been normal. After 
discontinuation of pentamidine the hyperglycemia 
persisted, requiring increasing doses of insulin. The 
patient was discharged from hospital wi th an aver-
age daily dose of 16 U insulin per day. Wi th in 12 
months later the average daily dose had increased 
to 70 U (Fig. 1). N o other risk factors for the devel-
opment of diabetes mellitus were found. There was 
no family history of diabetes mellitus, hemoglobin 
A l c was within the normal range at the onset of 
hyperglycemia, and test results for antibodies 
against islet cells were negative. Low C peptide lev-
els (1.5 ng/dl postprandial) indicated ß-cell dys-
function. 
Two weeks after discontinuation of pen-
tamidine the patient had an episode of nausea and 
vomit ing lasting for several days, accompanied by 
an increase in serum lipase to 490 U / l , serum amy-
lase remaining wi th in normal range. Over a period 
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Fig. 1. Postprandial blood glucose levels in the outpatient clinic 
and daily requirement of insulin over 9 months after discontinu-
at ion of pentamidine 
of 5 months lipase levels gradually returned to nor-
mal without further specific therapy. 
Discussion 
Pentamidine, an aromatic diamidine wi th antipro-
tozoal activity is used in the treatment of try-
panosomiasis, leishmaniasis, and most importantly 
P. carinii pneumonia. It appears to affect oxydative 
phosphorylation, nucleic acid synthesis, glucose 
metabolism, and folic acid synthesis, but the exact 
mechanism of its antiprotozoal effect is not yet 
known [5]. The drug can be administered by inhala-
tion, intramuscularly, and intravenously. Its vol-
ume of distribution is extremely high (3 1/kg) while 
the plasma half-life is very short (a few minutes) 
[12]. Experimental animal models show a high con-
centration of the drug in kidneys, liver, and lungs 
but also in other organs such as the pancreas after 
intravenous administration [6]. Seven days later the 
concentration of the drug in the organs remains 
almost unchanged [13]. Pentamidine is largely elim-
inated by renal excretion; a small proport ion is 
also eliminated by liver and salivary glands. 
Side effects of the drug are common, the most 
frequent of which are hypotension and hypo-
glycemia, the latter occurring in up to 26% of H I V -
infected patients treated by intravenous pen-
tamidine [7]. Persistent I D D M following pen-
tamidine has been reported in about 25 cases so far 
[3, 4, 7, 8, 10, 14]. There are 12 case reports from 
India on patients treated for kala-azar [8]. Eleven of 
these developed I D D M , one of whom could be suf-
ficiently treated by oral antidiabetics. A l l of these 
patients were followed up over the next 2-5 years 
and the diabetes persisted. The other reported cases 
of pentamidine-induced diabetes mellitus are A I D S 
patients treated wi th pentamidine for P. carinii 
pneumonia. There is only one case of non-insulin-
dependent diabetes mellitus caused by pentamidine 
[1]. While this was the case with the shortest dura-
t ion of therapy (9 days), the one wi th the longest 
duration (21 days) was accompanied by severe pan-
creatitis [14]. These clinical observations support 
the results of animal models in which the toxicity of 
pentamidine on the ß-cells of the pancreas ap-
peared time dependent, dose dependent, and irre-
versible [2, 3, 11]. Renal insufficiency has been 
shown to increase toxicity, but liver damage does 
not seem to affect toxicity of the drug [2]. A similar 
effect was observed after the administration of 
streptozotocin, alloxan, and certain rodenticides 
[9]. Histological examination of the pancreas was 
performed in one human who had developed dia-
betes mellitus after pentamidine treatment [14] and 
in rats exposed to pentamidine [2,11]. Morpholog-
ical changes differed from those found in the pan-
creas exposed to other toxic agents or in the pan-
creas of patients suffering from I D D M . The pan-
creas showed a decrease in ß-cells and an increase 
in Α-cells without ß-cell necrosis or lymphocytic 
infiltration. There is no further information about 
the exact mechanism of action of the drug's damag-
ing potential to ß-cells. 
The case described here emphasizes the toxicity 
of pentamidine to the pancreas. In this patient we 
found a slowly increasing need of insulin over 1 
year after pentamidine therapy which cannot be 
explained by dietary failure. Although the drug is 
known for its persisting and extremly high concen-
trations in almost all organs [10], it remains unclear 
how pentamidine can cause an increase of need of 
insulin even months after discontinuation of thera-
py. Further investigations must be performed to 
ascertain the exact mechanism of action of pen-
tamidine's high toxicity. 
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dermat i t is , photosensit ive 749 
desmin 150 
dexamethasone 1025 
- suppression test 887 
diabetes insipidus, drug- induced 769 
- nephrogenic 769 
diabetes mel l i tus 200, 558, 800,1027 
- insul in dependent 56, 494 
- non-insul in dependent 494 ,572 ,961 
dialysis 558,472 
dialysis, ambula to ry per i toneal 558 
diarrhea 167 
- enterotoxigenic 742 
diastolic dysfunction 874 
diastolic heart func t ion , impa i red 462 
diet induced thermogenesis 568 
diet , gluten-free 519 
d i l u t i on indicator 830 
d ipyr idamole 673 
discomfort , abdomina l 74 
disease (rotavirus , adenovirus) , v i ra l 167 
-cerebrovascu la r 775 
- -modi fy ing ant i rheumat ic d rug 535 
- f e t a l 794 
- i n f e c t i o u s 415 
d isod ium monof luorophosphate-ca lc ium 
1082 
disorder, chronic au to immune 822 
- mo toneu ron 892 
- h e m a t o l o g i c a l 939 
diuret ic , potassium-sparing 695 
diuretics 690, 708, 722 
diver t icula , l u m b a r 1056 
D N A p o l y m o r p h i s m 107 
- r e p a i r 930 
- sequence analysis 550 
- single-strand breaks 930 
D N A S E I foo tp r in t 687 
dopamine 262 
- m e s o l i m b i c 233 
dopaminergic D A I , r e c e p t o r agonist 60 
D o p p l e r sonography 331,465, 609 
-pu l sed -wave 462 
doxorub ic in 417 
drug effects, chol inergic 512 
drug in teract ion 1071,1076 
dysglycaemia 1027 
dys l ipoprote inemia 580, 800 
1094 
dysphagia 392 
dyspnea, nocturnal 372 
echocardiography 462 
-s t ress 206 
- transesophageal 206,465 
eczema, atopic 400 
edema 708 
- res i s tan t 722 
efficacy o f screening 117 
elastase 269,782 
elastase al-proteinase i n h i b i t o r 782,843 
electrolyte balance 830 
embolec tomy 465 
embol i sm, cerebral 465 
emphysema 269 
- p u l m o n a r y 404 
encephalitis, t ick-borne 399 
endocardit is 922 
ß - e n d o r p h i n 56,887 
endothel ia l cell adhesion molecule 639 
endothe l in 88 ,213 ,214 ,288 , 580,703 
- receptor subtypes 213 
endothelin-1 288 
endothe l ium 580 
-vascu l a r 88 
endothel ium-dependent re laxat ion o f 
vascular smooth muscle 88 
endothel ium-der ived contract i le factors 
580 
- re laxing factor 88 
- vasoconstricting factors 88 
energy expendi ture 568 
enterobacter 1015 
enterophathy 313 
eosinophil ia myalgia syndrome 541, 1060 
eosinophil ic fasciitis 1060 
epidoxorubic ine 209 
epistaxis 46 
ep i the l ium, colonic 742 
Epste in-Barr virus 883 
erectile dysfunction 138 
erect ion, prolonged/pr iapism 138 
erythema, necrolyt ic migra to ry 127 
erythrocytosis 341 
e ry th ropo ie t in 337,341 
esophagitis 343 
esophagus 343 
estrogens, conjugated equine 502 
ethanol 830,971 
e thy l i sopropylami lor ide 985 
e tomidate 481 
evans 'b lue 830 
ewing ra t io 996 
exercise 568 
fai lure, mu l t i o rgan 457 
fat aspirat ion, subcutaneous 462 
fatty acids 951 
- l o n g - c h a i n 957 
- s h o r t - c h a i n 742 
fecal occult b lood test, immunochemica l 
117 
femoral artery, superficial 592 
fenofibrate 294 
fenoldopam 60 
fer r i t in 26, 134 
fe r t i l i ty 838 
α - f e t o p r o t e i n 377 
F E V 1 772 
F E V 1 / V C 269 
fever 782 
f ibr inogen receptor 424 
- s u b s t i t u t i o n 395 
f ib romyalg ia syndrome 541 
f ibronec t in 316 
fibrosclerosis 788 
fibrosis 138 
f imbr ia lesion 262 
f low cy tomet ry 535 
f low-cy tomet r ic techniques 424 
5-fluouraci l 525 
flush, facial 331 
fol in ic acid 525 
fo l l ic le -s t imula t ing ho rmone 838,853 
formylmeth ionyl - leucyl -phenyla lan ine 
receptors 18 
fresh frozen plasma 794 
furosemide 722 
F V C 772 
gammopathy , monoc lona l I g M - k a p p a 46 
gastric juice 12 
gastric secretion 12 
gastroenterit is , acute 167 
gemfibroz i l 1065 
G e n - H - B - V a x - D 350 
gene expression 156 
generalized seizures 76 
genes, nuclear 251 
gentamicin 922 
glands, adrenal 979 
g lomerulonephr i t i s 404 
- id iopath ic membranous 277 
- rapid ly progressive 762 
glucagon 127,669 
glucagonoma 127 
glucocort icoids 701,782 
gluconeogenesis 569 
glucose 57, 569, 669 
- m e t a b o l i s m 94,568 
- tolerance, impa i r ed 887 
glycine 725 




gonadal funct ion 838 
gonadotropin-releasing ho rmone 838 
graft reject ion 609 
grand mal convulsions 76 
α - g r a n u l e membrane pro te in 424 
granulocyte macrophage colony 
s t imula t ing factor 390 
granulocyte colony s t imula t ing factor 390, 
417,522 
granulocyte 457 
- po lymorphonuc lea r 843 
- n e u t r o p h i l i c 18 
granulocyte-macrophage 457 
granulocytopenia 417 
Graves ' disease 390, 788 
g r o w t h ho rmone 56 ,489 ,508 ,669 
- releasing ho rmone 489,508 
guanine 409 
guanosine 3 ' ,5 ' -monophosphate, cvcl ic 
138 
gynecomastia 882,979 
H l ion concentra t ion 14 
hand's balanced salt so lu t ion 18, 30 
haptoglobin 1012 
Hashimoto ' s thyro id i t i s 788 
heart 209 
heart rate 512,996 
heart transplant recipients, 
immunosuppressed 350 







hemodialysis 424 ,430 ,472 ,558 , 1000 
- in metacresol poisoning 472 
-advanced-stage 754 
-ear lys tage 754 
-mid - s t age 754 
- o n s e t 754 
hemoglob in adducts 364 
hemophil iacs, H I V - i n f e c t e d 122 
hemoptysis 372 
hemorrhage, i n t r a tumora l 448 
hepar in , l ow molecular weight 913 
- unfract ioned 913 
hepatic lipase 100,294 
hepatit is 36, 794 
- Β 2 ,350,737, 1000, 1030 
- B e antigen 2 
- C virus infect ion 470 
- chronic active 36 
hepatocyte g rowth factor 558 
hepatoma cell lines, human 737 
hepatopathies 939 
heroin 471 
H G - 3 vaccine 350 
h iberna t ion 731 
high density l ipopro te in 100, 502, 580, 
631, 639, 660, 908, 944, 951 , 1065 
hippocampus, dorsal 262 
histiocytosis, fatal hematophagic 457 
h is tocompat ib i l i ty antigens 715 
histoplasma capsulatum 878 
histoplasmosis, disseminated 878 
H I V 50 ,111,122, 220,283, 288, 850, 878, 
1020,1027,1030,1037,1041 
H I V transmission 1 
Η L A class I antigens 321 
H L A systems 715 
H L A - B 2 7 321 
H M G - C o A 558 
homeostasis, f lu id-e lect rolyte 168 
hormone replacement therapy 502 
hormone , pa ra thyro id 341 
-paraneoplas t i c 337 
-vasoac t ive 685 
human cort icotropin-releasing ho rmone 
331 
human mucosal lymphocyte ant igen 1 313 
human mutS homologe 2 (gene) 619 
1095 
hydrochloro th iaz ide 1071,1076 
hydrocort isone 749, 782, 794 
hydrogen ion concentra t ion , t i t ra ted 12 
3-hydroxy-3-methylg lu tary l 
hydroxych lo roqu ine 750 
hydroxynicot ines 190 
5 ' -hydroxycot in ine 190 
17-hydroxyprogesterone 853 
1 l ß - h y d r o x y s t e r o i d dehydrogenase 701 
5-hydroxyt ryp tamine 541 
5-hydroxyt ryp tamine type 3 receptors 811 
5-hydroxyt ryp tamine type 1 A 451 
hyperaldosteronism 979 
hypercalcemia 448 
hypercholes terolemia 558 ,631,639,660, 
858, 898, 908, 939, 944,1065 
hypereosinophi l ic syndrome 1060 
hyperglycemia 800 
hyper insul inemia 568, 800, 853 
hvper l ip idaemia , f ami l i a l combined 100, 
' 5 5 8 
hyperostosis, diffuse id iopath ic skeletal 4 
- sternocostoclavicular 4 
hyperoxalur ia , p r i m a r y 725 
hyperpara thyro id ism, p r imary 448 
hyperplasia 979 
hyperprolac t inemia 302 
hyperreninemia 874 
hypertension 60, 88,708, 729.799,800, 
864,944 
- por ta l 653 
hypertensive crisis 60 
hyper thyro id i sm 26 
hyper tonic i ty 817 
hyper t rophy , ventr icular 359 
hypocholesterolemia 939 
hypoglycemia 56 
hypoka lemia 471,887 
h y p o m o t i l i t y , esophageal 343 
hypopi tu i ta r i sm 302 
hypotha lamic-p i tu i ta r iy axis 56 
hypoxemia , myocardia l 359 
ifosfamide 209 
I g A 519 
I g E 225,400 
I g G 220 
I g G 519 
I g M 519 
i l iac veins 40 




-synthes is 225 
- i n t r a v e n o u s 122,751,1051 
i m m u n o m o d u l a t i o n 400 
immunosuppress ion 535,1007 
immuno the rapy 525, 975 
indomethac in 385, 769 
infections 1015 
- b a c t e r i a l 122 
- f u n g a l 920 
in f l ammatory response syndrome 782 
in format ion-memory-concen t ra t ion test 
196 
inh ib i t i on , therapeut ic gastric 12 
inner membrane 252 
insul in 508,669 
- res is tance 571 
- human 56 
- p r o c i n e 56 
intensive care uni t 843 
intercel lular adhesion molecule-1 598 
in ter feron 225,870, 1030 
- i n t e r f e r o n - α 317 ,525 ,737 ,975 , 1030, 
- i n t e r f e r o n - γ 400,1041 
in t e r l euk in 225 ,315 ,711 , 782, 843 
- i n t e r l euk in 2 525,883,975 
in te r leukin-2 receptor, soluble 494, 598 
in t ima/media complex 874 
intracavernous inject ion 138 
intracranial pressure e lvat ion 1020 
iodine in take 967 
ion metabol i sm 168 
i ron -b ind ing capacity 26 
i ron supplementa t ion, ora l 519 
ischemia, l i m b 673 
- m y o c a r d i a l 359 
ischemic heart disease 731 
i traconazole 878,920 
kala-azar 1041 
Kaposi 's sarcoma 417, 1041 
ketoconazole 481 
kidney 168,448,692,708 
- functions 472 
- t r a n s p l a n t a t i o n 1000 
- tubular necrosis 609 
k i l l e r cells, lymphokineac t iva ted 525 
- n a t u r a l 535 
kinetics 1076 
L-lactates 951 
L D L apheresis 858 
L D L receptor defects 898 
leci thin : cholesterol acyltransferase 639, 
951 
left ventr icle 30 
left ventr icular end-diastolic pressure 430 
left ventr icular funct ion 442 
leiomyosarcomas 381 
leishamania donovan i i 1041 
leukocyte 424,870, 985 
- human mononuclear 985 
- p o l y m o r p h o n u c l e a r 30 
leukopenia 522 
- dialysis-associated 424 
L i - F r a u m e n i syndrome 619 
l i m b girdle musular dys t rophy 409 
l i n ton ba l loon 653 
l i p i d d i s t r ibu t ion 944 
l i p i d membranes 251 
l ipids 502 
l i pop ro te in 97,639, 951,1065 
- l i p a s e 94 
- m e t a b o l i s m 631,939 
l ipopro te in (a ) 558, 580, 660, 1065 
liposomes 417,1086 
l i tho t r ipsy 604 
l iver cirrhosis 138,572, 653 
-decompensa t ed 134 
l iver disease 36,1000 
- f u n c t i o n 1007 
- in jury 616 
- tests 36 
- t ransplantat ion 470 
l iver in jury , hepatocellular-cholestativ 
616 
l o w densit iy l ipopro te in 294, 502, 558, 
580, 631, 639, 660, 858, 898, 908, 944, 
1065 
lung cancer 156, 240 
- s m a l l - c e l l 156 
- n o n - s m a l l - c e l l 156 
l u n g capacity, to ta l 269 
l u n g funct ion 772 
lupus erythematosus, systemic 749,762, 
920 
lu te in iz ing ho rmone 838, 853 
l y m p h node abscess 1037 
lymphocy te p ro l i f e ra t ion 220 
lymphocy te subsets 535 
lymphocytes 817,930 
l y m p h o m a , intestinal 313 
a2-macrog lobu l in 196 
macrophage 639 
magnesium 175 
magnet ic resonance imaging 85 ,302 ,462 . 
1020, 1056 
malar ia , cerebral 598 
malignancies, p r imary cardiac 372 
ma lony l coenzyme A 77, 957 
manganese powder 830 
mann i to l 830 
manomet ry , long- term 343 
medica t ion , immunosuppressive 350 
melanoma 975 
melphalan 462, 522 
meningi t is , cryptococcal 1020 
meningoencephal i t is 850 
mesothel ioma, mal ignant 317 
metabol ic syndrome 800 
metabol i sm, basal 568 
- e n e r g y 568 
- i n t e r m e d i a r y 568 
- l i p i d 568 
- postprandial 568 
- w a t e r - e l e c t r o l y t e 168 
5 me thy lu rap id i l 55 
metastasis 209,377 
methenamine silver stain 878 
meth imazole 390 
methylpredniso lone 1025 
metyrapone 481 
mic roa lbuminur i a 961 
mic rob io logy 415 
ß - m i c r o g l o b u l i n 321 
microspheres 775 
m i n i - m e n t a l state examina t ion 196 
m i n i l i t h o t r i p t e r 604 
M i r 168 
mi tochondr i a 251,359 
mi tochondr i a l hsp70 257 
mi to tane 481 
m i t r a l valve 922 
monocyte chemoat t ractant protein-1 639, 
711 
mononucleosis-gastroenteri t is 1048 
m o r t a l i t y , hospital 939 
1096 
Mul t i cen te r A I D S Cohor t Study 111 
mul t ip l e myeloma 522 
muscle, smooth 639 
mushroom poisoning 794 
mycobacer ium av ium i n t r a c e l l u l a r 850 
mycobacteria, nontuberculous 850 
- tube rcu los i s 107 
myelofibrosis 878 
myelography, lumbar 1056 
myeloma 522 
myocardia l infarc t ion 435, 951 
myocard ium, h iberna t ing 442, 731 
myofibri l logenesis 150 
myopa thy metabol ic 77 
myoton ic dystrophy 409,508 
myotubes, ma tured 150 
N-acetyl-4-amino-ant ipyr ine 830 
N - a c e t y l - ß - g l u c o s a m i n i d a s e 799 
n-butyrate 742 
N- iOrmyl-meth ionyl - leucyl -phenyla lan ine 
30 
N-formyl-nor leucyl - leucyl -phenyla lanyl -
norleucyl- tyrosyl- lysine 353 
N-methv l -N ' -n i t ro -N-n i t rosoguan id ine 
930 
N a 7 H ' an t ipor t 817 
N a ' / H 4 an t ipor ter act ivi ty 985 
Na-Cl cotransport 692 
N a - K - A T P a s e 992 
N a - K - C l cotransport 692 
N A S A 168 
nasal snuff 364 
natr iuret ic pepi tde, type A 772 
natr iuret ic peptides 179 
nebul in 150 
necrosis, renal cortex 499 
neoplasia, mul t ip le endocrine 729 
nephrit is , L E 749 
- lupus 765 
nephrocalcinosis 725 
nephroli thiasis, a m m o n i u m urate 385 
nephron, jux tamedu l l a ry 682 
nephropathy, l ight-chain 522 
- m e m b r a n o u s 277 
nephrot ic syndrome 404, 558 
nervous system, autonomic 996 
neurofibromatosis 619 
n e u r o n o p h a g y , X - l i n k e d recessive 
bulbospinal 892 
neurons, nigrostr iatal dopamine 262 
neuropathy, au tonomic 200 
- p e r i p h e r a l 200 
- s e n s o r y 822 
neuropept ide Y 685 
neu t roph i l 18,782 
- po lymorphonuc lear 269,353 
nick translat ion 930 
nicot ine 65, 94, 225, 233,512, 908, 925 
- infusion 262 
- t a r t r a t e 94 
- i m i n i u m ions 190 
nifedipine gastrointestinal therapeutic 
system 864 
ni t r ic oxide 88,685 
nitrosamines, tobacco-specific 364 
nocicept ion 65 
non-ergot D2-dopamine agonist 451 
non-hodgkin ' s l y m p h o m a 457 
nonsmokers 512,804 
nonsteroidal an t i - in f lammatorv d r u » 535, 
811 
noradrenal ine 685, 874 
normotens ion 775 
nucleotides eytosine 409 
nucleus accumbens 233 
nu t r i t i ona l status 754 
obesity 800 
obst ruct ion, r ight ventr icular ou t f low 359 
octreot ide 127,653 
ol igonucleot ides 737 
oncogenes 156 
ondansetron 811 
opiate overdose 471 
optha lmoplegia 302 
orthostasis, active 996 
osmola l i ty 172 
osteomyeli t is , recurrent chronic mul t i foca l 
4 
osteoporosis 1082 
ouabain, endogenous 706 
outer membrane 252 
oxalosis, systemic 725 
o x i p u r i n o l 1071,1076 
oxygen superoxide 18 
p53 619 
pain 65 
pancreas 377, 1027 
pancytopenia 457 
panhypopi tu i ta r i sm 302 
papi l loma viruses, human 619,870 
paracrine interactions 682 
paraprote inemia 46 
parasites 1041 
para thyro id 448 
parkinsonism 489 
parot i t i s 1037 
parvovirus Β 19 1051 
patients, septic 18 
P E F 772 
penic i l l in 794,922 
pentamidine 1027 
peptidase, mi tochondr i a l processing 252 
percutaneous t ransluminal coronary 
angioplasty 442,731 
per ipheral t rans luminal angioplasty 592, 
673 
per iphera l vascular disease 673 
p H - m e t r y , intragastric 12 
pheochromocy toma 729 




phospholipase A 2 782 
phosphol ipids 951 
physical exercise 804 
p i tu i ta ry hormones 804 
placebo 961 
plasmocytoma 883 
Plasmodium falciparum 598 
platelet 639,673 
platelet aggregat ion 424 
p la te le t -der ived g r o w t h factor 639 
plexus neuropa thy , postvaccinal 399 
plus maze 233 
Pneumocyst is ca r in i i pneumonia 111, 
1027,1037 
podagra 811 
p o i n t mu ta t ions 240 
polycyst ic ova ry syndrome 853 
po lyendoc r inopa thy , au to immune 494 
polymerase cha in react ion 240,550, 898 
p o l y m o r p h i s m 240 
p o l y n e u r o p h a t h y 822,1060 
polyposis c o l i , adenomatous 619 
polysaccharide, nonstarch 742 
postmenopause 502 
potass ium 175,471 
pravasta t in 1065 
p r e a l b u m i n 1012 
precarcinoconogens 240 
precursor p ro te ins 252 
prediabetes 494 
predniso lone 277 
- e x o g e n o u s 701 
prednisone 462, 701 
preeclampsia 799 
preglucagon 127 
pregnancy 794, 799 
preprog lucagon 127 
p r e p r o t e i n receptors 252 
p r i m a r y cell cu l tu re 317 
p r o e n k e p h a l i n 925 
prognosis 585 
progressive systemic sclerosis 343. 541 
p ro l ac t i noma 451 
pros tag landin Ε 385 
- r e n a l 385 
- E , 138 
- E 2 769 
p r o t e i n f o l d i n g 252 
p r o t e i n kinase C 18 
p r o t e i n lipase 100 
p r o t e i n tyrosine kinases 713 
proteinase i n h i b i t o r Ζ 404 
p r o t e i n u r i a 462 
p r o t h r o m b i n ac t ivat ion fragments 395 
pseudohypopara thyro id i sm 341 
psychological stress 804 
publ ica t ions , scientific 555 
p u l m o n a r y capi l la ry wedge pressure 465 
p u l m o n a r y e m b o l i 40 
pulsa t i l i ty index 609 
rad io the rapy 838 
r a n d o m m i g r a t i o n 30 
ra t 775 
@sprague-dawley 262 
- spontaneously hypertensive 88 
receptor , a m i l o r i d e 695 
- n ico t in ic 262 
r ecombinan t tissue-type plasminogen 
ac t iva tor 465 
rectoscopy 381 
r ec tum 381 
renal b l o o d f low 685 
renal cell ca rc inoma 337,619 
rena l disease 558,708,711 
1097 
renal fa i lure 522 
- a c u t e 609,499 
- dialysisdependent chronic 430 
- end-stage 353,424,754 
renal funct ion 685,703 
renal insufficiency 277 
renal microc i rcula tory func t ion 682 
renal microvasculature 682 
renal stone disease 550 
renal tubules 698 
ren in 177 
renin con t ro l 687 
reperfusion injury 719 
residual vo lume 269 
resistance 1015 
- p e r i p h e r a l 60 
resistive index 609 
respi ra tory chain 359 
respira tory quotient 568 
respira tory tract 215 
restenoses 673 
restr ic t ing fragment length p o l y m o r p h i s m 
107,453,550,898 
re t ina l microangiopathic syndrome 288 
re t inoblas toma (gene) 619 
r e t i n o i c a c i d 1086 
rhabdomyolysis 77 
rhabdomyosarcomas 150 
r h e u m a t o i d arthrit is 535 
r h e u m a t o i d factor 535 
ribosomes 251 
r ibozymes 737 
Riedel 's s truma 788 
r i fabu t in 850 
risk factor 240, 435 
R N A , tissue 156 
R N A - 1 , Epste in-Barr virus encoded 883 
rochal imaea 50 
r o x i n d o l 451 
salicylic acid 749 
saline infusion 817 
saline, isotonic 971 
salivary duct stones 604 
Salyut 168 
sarafotoxin 88,213 
sarcoma, embryona l 209 
- u n d i f f e r e n t i a t e d 209 





sensorimetry, quanti tat ive 
sepsis 18,782 
septal defect, ventr icular 359 
septum, interventr icular 462 
seroconversion 122 
serotonin 451,541,811 
serum amylo id A pro te in 1007 
sex ho rmone metabol ism 751 
shock 782 
- wave t reatment 604 
- c a r d i o g e n i c 465 
sialolithiasis 604 
sicca syndrome 822 
signal t ransduct ion 353,713 
silent ischemia 307 
s i l ib in in 794 
singele-strand confo rmat ion 
po lymorph i sm 898 
single-photon emission computed 
tomography 731 
Sjogren's syndrome 822 
skin disease, chronic in f l ammatory 400 
sleep-wake cycle 315 
small intestine 313 
small nerve fiber funct ion 822 
smokers ' ur ine 190 
smokers 269,364,804, 930 
- h a b i t 512 
-pass ive 364 
smooth muscle, vascular 992 
SMS 201-995 669 
sodium 172,800,817 
- f l u o r i d e 1082 
- reabsorpt ion 722 
somatostat in 127, 653, 669, 887 
space flights, long- term 168 
spinal cord 65 
spinal muscular a t rophy 882 
spironolactone 695, 979 
Spondarthritis, pustulopsoriat ic 
hyperostot ic Spondarthrit is 4 
spondyloar thropathies , seronegative 321 
sports 399 
squamous cell carcinoma 240 
standarized m o r t a l i t y ra t io 117 
steroid biosynthesis inh ib i tors 481 
steroid, cardiotonic 706 
streptococcus mit is 922 
streptococcus pneumoniae 1037 
strictures 343 
study, longi tud ina l 117 
s tunning 731 
subarachnoid hemorrhage 302 
suggestibil i ty 512 
sulfur d ioxide 215 
superoxide anion 18 
superoxide dismutase 719 
superoxide p roduc t ion 353 
sural nerve 65 
surgery t h y r o i d 967 
syncope 372 
Τ cells 321 
tachyar rhy thmia 307 
tachycardias, hypotensive 775 
T a q I R F L P 550 




te t ra logy o f fa l lot 359 
thalamus 65 
therapy, an t ib io t ic 1015 
- diuret ic 985 
- f ib r iono ly t i c 465 
- immunosupp re s s ive 749 
- r e h y d r a t i o n 167 
- s u b s t i t u t i o n 395 
thiazides 692 
th iobarb i t a l 775 
t h i o c t i c a c i d 794 
thiocyanate 830 
thiosulfate 830 
th iourea 830 
t h rombec tomy 40 
t h r o m b i n act ivat ion 395 
th romboembol i c , prophylaxis 913 
t h r o m b o m o d u l i n 598 
thrombosis 40 ,465,883 
th romboxane 673 
thymine 409 
t h y r o i d cysts 971 
t h y r o i d dysfunction 975 
thyro id - s t imula t ing ho rmone 489 ,971 , 
975 
- releasing ho rmone 489 
thyrox ine 26 ,967 ,971 ,975 
t i l t table 996 
tobacco smok ing 238,930 
tob ramyc in 1015 
t r amado l 76 
t rans-3 ' -hydroxycot inine 190 
trans-activating factors 687 
t ransferr in 1012 
t ransforming g r o w t h factor 558, 713 
transplant reject ion 715 
t ransplanta t ion 715 
- k i d n e y 609 
- l i v e r 1007 
- r e n a l 1000 
- renal cadaveric 719 
transport , mucoci l ia ry 215 
t rauma 18 
- m u l t i p l e 843 
t r e t ino in 1086 
t r iamcinolone 100, 294,502, 749, 944, 
1065 
t r i i odo thy ron ine 26 ,944,971 
tr i lostane 481 
t r i t o n C-100 77 
t r i t o n X-100 957 
T r y p s i n 957 
tuberculosis, pu lmona ry 107 
tubula r actions 690 
tubu log lomeru la r feedback 682 
t u m o r b io logy 156 
- c a c h e x y 127 
- cell marke r 337 
- g r o w t h 127 
t u m o r necrosis factor 18,94, 225, 470, 
472 ,525 ,711 ,782 ,843 
t u m o r suppressor genes 619 
- v i r u s e s 619 
-gas t ro in tes t ina l 525 
- mal ignant bronchogenic 156 
ul t rasound 435 ,585 ,604 ,609 
- e n d o r e c t a l 381 
- t h y r o i d 967,971 
u remia 353 
ureter, human 213 
ure thra , human 55 
ur ic acid 385,1071 
uroli thiasis 725 
- 2 ,8-dihydroxyadenine 550 
vaccinat ion 350 
valvular heart disease 30 
1098 
variceal b leed ing 653 
vascular cell adhesion molecule-1 598 
vascular disease 288 
vascular system 85 
vasculopathy, ch ron ic t ransplant 719 
vasoconstr ic tor 214 
vasopressin 653,698 
ven t r i cu la r f i b r i l l a t i o n 307 
ven t r i cu la r pac ing 775 
very l o w densi t iy l i p o p r o t e i n 100,294, 
502, 568, 639, 944,1065 
vigi lance 512 
v i t a m i n Κ 794 
v o n H i p p e l - L i n d a u s y n d r o m e 619, 729 
W a l d e n s t r ö m s m a c r o g l o b u l i n e m i a 46 
W a l t e r reed classif ication 288 
warts , genital 870 
wate r 172 
-channe l -co l lec t ing duct 698 
- c h a n n e l s 698 
- D 2 1 s O 830 
- t r a n s p o r t 698 
- t o t a l body 830 
- t r i t i a t e d 830 
Wegener ' s granulomatos is 762 
weightlessness 168 
w i l d type p53-act ivated f ragment 619 
W i l m s ' t u m o r (gene) 619 
Wilsons 's disease 134 
X chromosome 728 
xe roph tha lmia 822 
xeros tomia 822 
z idovud ine 111 
zinc, ur ine 1012 
zymosan ac t iva ted plasma 
